# Agilent Technologies to acquire Biocare Medical for $950M

Agilent Technologies Inc. has entered into a definitive agreement to acquire Biocare Medical, a global leader in clinical pathology, from an investor group led by Excellere Partners and GHO Capital Partners LLP, in an all-cash transaction valued at $950 million.

- Type: Acquisition
- Announced: 2026-03-09
- Where: United States
- Value: $950.0M
- Status: announced
- Products: immunohistochemistry (IHC) solutions, in situ hybridization (ISH) solutions, fluorescence in situ hybridization (FISH) solutions, specialized antibodies
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Agilent Technologies](https://endata.com/companies/1947.md) (acquirer)
- [Biocare Medical](https://endata.com/companies/39171.md) (target)
- [Excellere Partners](https://endata.com/companies/39172.md) (investor)
- [GHO Capital Partners](https://endata.com/companies/39173.md) (investor)

## Sources

- [investor.agilent.com](https://www.investor.agilent.com/news-and-events/news/news-details/2026/Agilent-to-Acquire-Biocare-Medical-a-Global-Leader-in-Clinical-and-Research-Pathology-Solutions/default.aspx), 2026-03-09: "The acquisition of Biocare enhances Agilent’s pathology portfolio and reflects our strategy to drive long-term growth through customer-centric innovation and disciplined capital allocation."
- [barchart.com](https://www.barchart.com/press-releases/634928/agilent-to-acquire-biocare-medical-a-global-leader-in-clinical-and-research-pathology-solutions), 2026-03-09: "Agilent Technologies Inc. (NYSE: A) today announced it has entered into a definitive agreement to acquire Biocare Medical, a global leader in clinical pathology, from an investor group led by Excellere Partners and GHO Capital Partners LLP, in an all-cash transaction valued at $950 million."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.